ReviewJournal of fluorescence2025
Transition Metal Complexes as Antibacterial Agents: An Overview.
Review in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Monomeric Zn(II) and 3D polymeric Ag(I) complexes with a cationic s-triazine hydrazone-based ligand; synthesis, structure, coordination behavior and biological studies.Scientific reports · 2026Article
- Coordination Metal Complexes With Antibacterial and Antioxidant Functions for Food Packaging: From Single-Function Systems to Intelligent Materials.Comprehensive reviews in food science and food safety · 2026Review
- Antimicrobial, antibiofilm, antioxidant activities and molecular docking of Schiff base and its complexes of Cu(II), Co(II), Ni(II), Mn(II) and UOScientific reports · 2026Article
- Metal-antibiotic interactions: potentiometric and spectroscopic investigation of cloxacillin and dicloxacillin complexes in aqueous solution.Scientific reports · 2026Article
- Design, Synthesis, and Bioevaluation of Moxifloxacin Hydrazide Metal Complexes: Integrated Spectroscopic, Computational, Antimicrobial, and Anticancer Investigations.International journal of molecular sciences · 2026Article
- Water-Soluble Palladium Complexes with 1,10-Phenanthroline-Synthetic Aspects, Crystal Structure, DNA-Binding and In Vitro Antibacterial Evaluation.Molecules (Basel, Switzerland) · 2026Article
- Copper(II) Complexes of Selected Acylhydrazones as Potential Biological Agents.International journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the vacant d-orbitals, variable oxidation states, and coordination geometries of transition metals, they have a tendency to form complexes with variety of ligands. The effectiveness of these transition metal complexes as therapeutic agents has been demonstrated in various domains, such as antibacterial, anti-cancer, anti-fungal, anti-diabetic, and anti-malarial. We have reviewed the antibacterial investigations of several transition metal complexes spanning last few years in this review. Upon reviewing the literature, it has been found that metal complexes work better against bacteria than free ligands do. Almost, all the investigations in literature review have come to the conclusion that the nature of the ligand, the nature of the metal ion, the metal's oxidation state, coordination behavior, symmetry, and the stability of the complexes are the key factors responsible for the increased antibacterial activity of metal complexes. Furthermore, after complexation, the metal complexes exhibit enhanced lipophilicity and increased facile translocation through the cellular membrane. Additionally, in contrast to free ligands, the stability and antibacterial activity of metal complexes increased as a result of chelation.
Indexed as
Identifiers
40272689What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.